More specialists question safety of testosterone therapy for older men

More specialists question safety of testosterone therapy for older men
Endocrine Society echoes recent FDA concerns about the popular supplements.

(HealthDay)—Following the recent announcement from the U.S. Food and Drug Administration about the potential hazards of using testosterone supplements in older men, another group of experts is raising concerns about the popular treatments.

In a statement, specialists in hormonal therapy at the Endocrine Society said the risks and benefits of supplements for with age-related declines in must be investigated more carefully.

Older men considering such regimens should be warned about the possible risks, particularly heart-related events such as and stroke, the group said.

The Endocrine Society issued the warning after three recent studies revealed testosterone may not be safe for older men with a history of heart disease. The studies found these men had more heart-related events than men not on .

For example, in one study published recently in the journal PLoS One, an increased risk of heart attack was found in men younger than 65 with a history of , and in older men even if they didn't have a history of the disease.

Testosterone therapy has been widely advertised as a way to help aging men improve low sex drive and reclaim diminished energy, and use of the supplements is on the increase. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it has not been approved for treating age-related declines in testosterone levels.

Earlier this month, the FDA announced it is "investigating the risk of stroke, heart attack and death in men taking FDA-approved testosterone products," based on the recent studies.

The U.S. National Institute on Aging is also expected to release the results of research on the safety of testosterone. The study involved roughly 800 older men with low testosterone and symptoms associated with this condition, such as sexual and physical dysfunction. Since the men's heart health was carefully monitored, the research is expected to shed more light on the safety of testosterone therapy.

The Endocrine Society added that more large, randomized controlled studies are needed to investigate the risks and benefits of the treatment for older men. Meanwhile, the group advised that middle-aged and older men who are thinking about using testosterone therapy to treat age-related declines in this hormone should be warned about the possibility of heart-related side effects.

The group said it is especially important for men who've had a heart attack, stroke or other heart-related event in the past six months to avoid testosterone therapy.

On the other hand, testosterone therapy is safe and effective for the treatment of young men with hypogonadism (testosterone deficiency) that resulted from a disease of the testes, pituitary or hypothalamus. These patients should talk to their doctor before making any changes to their treatment plan.

More information: The American Academy of Family Physicians provides more information on testosterone therapy.

add to favorites email to friend print save as pdf

Related Stories

FDA will review safety of testosterone therapy

Feb 03, 2014

(HealthDay)—Spurred by a recent report that popular testosterone treatments might raise men's heart risk, the U.S. Food and Drug Administration says it now plans a review of the therapies' safety.

Testosterone therapy might increase heart attack risk

Jan 29, 2014

(HealthDay)—Testosterone therapy—widely advertised as a way to help men improve a low sex drive and reclaim diminished energy—might raise the risk of heart attack, according to new research.

Recommended for you

Growing a blood vessel in a week

13 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

16 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments